Results 231 to 240 of about 12,203,194 (406)

Interplay between RNA‐protein interactions and RNA structures in gene regulation

FEBS Open Bio, EarlyView.
Methodological advances in mapping transcriptome‐wide RNA‐protein interactions and RNA structures have started to uncover the potential of RNP conformations in gene regulation. Competing RNA–RNA, RNA‐protein and protein–protein interactions shape the compaction and function of RNPs throughout their lifetime and may provide novel therapeutic targets in ...
Jenni Rapakko, Mauro Scaravilli, Minna‐Liisa Änkö   +2 more
wiley   +1 more source

Diagnostic Applications of Artificial Intelligence in Liver Diseases. [PDF]

J Clin Med
Bragazzi MC, Venere R, Andriollo G, Ridola L, Alvaro D.   +4 more
europepmc   +1 more source

ON THE ACTION OF COD-LIVER OIL AS A CURATIVE AGENT IN THE TREATMENT OF DISEASE. [PDF]

Robert P. Glover
openalex   +1 more source

Diseases of the Bile Passages, Including the Liver, Gall-Bladder and Pancreas [PDF]

, 1906
MAURICE H. RICHARDSON
openalex   +1 more source

Tryptophan metabolite atlas uncovers organ, age, and sex‐specific variations

FEBS Open Bio, EarlyView.
Tryptophan metabolites were analyzed across twelve organs, the central nervous system, and serum in male and female mice at three life stages. We found tissue‐, sex‐, and age‐specific differences, including increased indole‐3‐pyruvate and kynurenine in aging males.
Lizbeth Perez‐Castro, Afshan F. Nawas, Jessica A. Kilgore, Pedro A. S. Nogueira, M.Carmen Lafita‐Navarro, Paul H. Acosta, Roy Garcia, Noelle S. Williams, Maralice Conacci‐Sorrell   +8 more
wiley   +1 more source

Metallothioneins in the Pathogenesis of Liver Diseases: A Review. [PDF]

Int J Hepatol
Nowicka AA, Gomułkiewicz A, Serafińska S, Simon KA, Dzięgiel P.   +4 more
europepmc   +1 more source

LIVER VITAMIN B12 LEVELS IN CHRONIC LIVER DISEASES

, 1959
Nobuo Kato, Yoshinori Narita, SHIGECHIKA KAMOHARA   +2 more
openalex   +2 more sources

Liver Failure and Liver Disease [PDF]

Hepatology, 2006
openaire   +3 more sources

Indoleamine 2,3‐dioxygenase 1 inhibition reverses cancer‐associated fibroblast‐mediated immunosuppression in high‐grade serous ovarian cancer

FEBS Open Bio, EarlyView.
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee, Jung Yoon Ho, In Sun Hwang, Youn Jin Choi   +3 more
wiley   +1 more source

The impact of aging on liver health and the development of liver diseases. [PDF]

Hepatol Commun
Williams SN, Ding WX.
europepmc   +1 more source